Nalaganje...
Targeting BRAF‐Mutant Non‐Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy
Non‐small cell lung cancer (NSCLC) remains the leading cause of cancer‐related deaths globally. However, the identification of oncogenic driver alterations involved in the initiation and maintenance of NSCLC, such as epidermal growth factor receptor mutations and anaplastic lymphoma kinase transloca...
Shranjeno v:
| izdano v: | Oncologist |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5507646/ https://ncbi.nlm.nih.gov/pubmed/28487464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0458 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|